| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $75.8M | +158.0% |
| SG&A Expense | $20.9M | +287.5% |
| Operating Income | -$96.7M | -178.1% |
| Interest Expense | $1.6M | -67.5% |
| Net Income | -$98.1M | -139.7% |
| EPS (Basic) | -$16.53 | +84.2% |
| EPS (Diluted) | -$16.53 | +84.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $405.7M | — |
| Current Assets | $409.5M | — |
| Total Assets | $453.0M | +4322.9% |
| Current Liabilities | $21.2M | -52.1% |
| Total Liabilities | $47.6M | +4.8% |
| Stockholders' Equity | $405.4M | +1250.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.2M | -179.2% |
| Investing Cash Flow | -$9.0M | -174.0% |
| Financing Cash Flow | $494.6M | +1346.8% |